Start on a low dose and increase gradually
Unlike existing approved therapies, it simultaneously targets GLP-1, GIP, and glucagon receptors, a mechanism that early clinical data suggest may produce substantial metabolic effects
Further, the absolute risk reduction is small, which translates into a comparatively high number needed to treat of 67
This effect is also partially enhanced by its duality as an inhibitor of HATs (Xia et al., 2012)
The length of telomere in humans is relatively short (5 to 15 kb) [45] which is shorter than mice (50 kb) [46], however humans have much longer life span compared with mice
The recipes are also lower in sugar and saturated fat to support weight-management goals